Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
7(54%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
13
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution13 total trials
N/ANon-phased studies
13(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

13

all time

Status Distribution
Active(10)
Completed(3)

Detailed Status

Recruiting5
Completed3
Not yet recruiting3
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
13
Active
7
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A13 (100.0%)

Trials by Status

completed323%
not_yet_recruiting323%
recruiting538%
active_not_recruiting215%

Recent Activity

7 active trials
Showing 5 of 13
recruitingnot_applicable

Alpha Radiation Emitters Device (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

NCT06698458
not_yet_recruitingnot_applicable

Treatment of Locally Recurrent Prostate Cancer

NCT07290998
recruitingnot_applicable

A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer

NCT05657743
not_yet_recruitingnot_applicable

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

NCT06755359
recruitingnot_applicable

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

NCT03889899
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT06698458Not Applicable

Alpha Radiation Emitters Device (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

Recruiting
NCT07290998Not Applicable

Treatment of Locally Recurrent Prostate Cancer

Not Yet Recruiting
NCT05657743Not Applicable

A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer

Recruiting
NCT06755359Not Applicable

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

Not Yet Recruiting
NCT03889899Not Applicable

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

Recruiting
NCT04543903Not Applicable

Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer

Completed
NCT04540588Not Applicable

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Completed
NCT04002479Not Applicable

Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer

Active Not Recruiting
NCT05632913Not Applicable

Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer

Recruiting
NCT03737734Not Applicable

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

Active Not Recruiting
NCT04534127Not Applicable

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Recruiting
NCT05065346Not Applicable

Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC

Not Yet Recruiting
NCT03353077Not Applicable

Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)

Completed

All 13 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
13